Literature DB >> 16474849

Functional characterization of novel presenilin-2 variants identified in human breast cancers.

M D To1, N Gokgoz, T G Doyle, D B Donoviel, J A Knight, P S Hyslop, A Bernstein, I L Andrulis.   

Abstract

We identified in breast cancer cases two germline alterations, R62H and R71W, in presenilin-2 (PS-2), a gene involved in familial Alzheimer's disease (FAD). The role of these alleles in FAD is unclear, but neither allele affected Abeta(42)/Abeta(40) ratio. However, both R62H and R71W alterations compromised PS-2 function in Notch signaling in Caenorhabditis elegans and cell growth inhibition in mouse embryonic fibroblasts, and these effects were dependent on gene dosage. We found that both alterations enhanced the degradation of the PS-2 full-length protein, indicating that they may have a loss-of function effect. The effect of the R71W alteration was noticeably stronger, and we observed an almost threefold higher frequency of this allele in breast cancer cases versus controls, but this difference did not reach statistical significance. Nonetheless, these results collectively suggest that the novel PS-2 alleles described here, especially R71W, affect PS-2 function and may potentially confer a moderate risk of susceptibility to breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474849     DOI: 10.1038/sj.onc.1209397

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Presenilin-2 gene mutation presenting as Lewy body dementia?

Authors:  Loredana Raciti; Alessandra Nicoletti; Francesco Le Pira; Virginia Andreoli; Donatella Contrafatto; Salvatore Lanzafame; Tiziana Maci; Antonio Gambardella; Aldo Quattrone; Mario Zappia
Journal:  Neurol Sci       Date:  2011-03-16       Impact factor: 3.307

2.  Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7.

Authors:  V Rocher-Ros; S Marco; J-H Mao; S Gines; D Metzger; P Chambon; A Balmain; C A Saura
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

3.  Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.

Authors:  Gabriel Frampton; Monique Coufal; Huang Li; Jonathan Ramirez; Sharon DeMorrow
Journal:  Exp Cell Res       Date:  2010-03-25       Impact factor: 3.905

4.  Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy.

Authors:  Davide Gianni; Airong Li; Giuseppina Tesco; Kenneth M McKay; John Moore; Kunal Raygor; Marcello Rota; Judith K Gwathmey; G William Dec; Thomas Aretz; Annarosa Leri; Marc J Semigran; Piero Anversa; Thomas E Macgillivray; Rudolph E Tanzi; Federica del Monte
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

5.  Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer's disease case.

Authors:  Paola Piscopo; Giuseppina Talarico; Lorenzo Malvezzi-Campeggi; Alessio Crestini; Roberto Rivabene; Marina Gasparini; Giuseppe Tosto; Nicola Vanacore; Gian Luigi Lenzi; Giuseppe Bruno; Annamaria Confaloni
Journal:  J Neurol       Date:  2011-05-05       Impact factor: 4.849

6.  RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling.

Authors:  Bei Liu; Liang Wang; Liang-Liang Shen; Ming-Zhi Shen; Xiao-Dong Guo; Tao Wang; Qin-Chuan Liang; Chao Wang; Jun Zheng; Yi Li; Lin-Tao Jia; Hua Zhang; Guo-Dong Gao
Journal:  Neuro Oncol       Date:  2012-06-29       Impact factor: 12.300

7.  Changes in the expression of the Alzheimer’s disease-associated presenilin gene in drosophila heart leads to cardiac dysfunction.

Authors:  A Li; C Zhou; J Moore; P Zhang; T H Tsai; H C Lee; D M Romano; M L McKee; D A Schoenfeld; M J Serra; K Raygor; H F Cantiello; J G Fujimoto; R E Tanzi
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

8.  Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia.

Authors:  Maura Gallo; Carmine Tomaino; Gianfranco Puccio; Francesca Frangipane; Sabrina A M Curcio; Livia Bernardi; Silvana Geracitano; Maria Anfossi; Maria Mirabelli; Rosanna Colao; Franca Vasso; Nicoletta Smirne; Raffaele G Maletta; Amalia Cecilia Bruni
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

Review 9.  Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders.

Authors:  Yan Cai; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2015-07-14       Impact factor: 4.458

10.  Gamma secretase inhibitors of Notch signaling.

Authors:  Roma Olsauskas-Kuprys; Andrei Zlobin; Clodia Osipo
Journal:  Onco Targets Ther       Date:  2013-07-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.